Feinberg investigators continue to investigate new treatments for COVID-19 and share insights on combating misinformation and mitigating the disease’s spread.
Overall mortality for patients hospitalized for COVID-19 in the U.S. during the first half of 2020 was 18.4 percent, with more than half of all deaths occurring in Black and Hispanic patients, according to findings published in the journal Circulation.
Northwestern Medicine investigators have shown how COVID-19 pneumonia is different from typical cases of pneumonia, spreading across the lungs like multiple wildfires and leaving tissue damage in its wake.
Take a look back at a handful of groundbreaking research discoveries that marked one of, if not the most, unprecedented and transformative years for Feinberg.
Listen to the year’s most popular episodes of the Breakthroughs podcast, featuring Northwestern Medicine experts discussing COVID-19 research.
Northwestern Medicine physicians have begun receiving their vaccines, an experience that for many was inspiring, sobering and hopeful. Read the reactions of a few Northwestern Medicine physicians upon receiving their COVID-19 vaccines.
Double lung transplants performed by Northwestern Medicine surgeons in patients with irreversible lung damage from COVID-19 helped save lives, according to a recent study.
A gene mutation discovered in a small Amish community in Indiana has inspired the use of a new experimental drug for COVID-19 that reduces blood clotting.
In late March, the world came to a virtual standstill. The COVID-19 pandemic forced leaders around the world to limit large gatherings and shutter schools and businesses. For Feinberg’s research enterprise, this was a serious disruption — but science kept moving forward.
Second-year medical students Jeff Clark, Nathan Shlobin, and Steven Hoffman are the co-authors of a first of its kind study, which found that more than 80 percent of patients hospitalized with COVID-19 experienced neurological manifestations.